Yuxiao Wang

Dr. Wang joined Myeloid Therapeutics in March 2019 as one of the co-founders. He received his Ph.D. in Molecular Biophysics from the University of Texas Southwestern Medical Center and performed his postdoctoral research at Prof. Ron Vale’s laboratory at the University of California, San Francisco. Dr. Wang published several papers on transmembrane receptor signaling, T-cell signal transduction, and membrane trafficking. He has received the Jane Coffin Childs Fellowship Award (2014) and the UCSF Independent Research Award (2017).